DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “SOLIRIS Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about SOLIRIS for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the SOLIRIS for PNH in the 7MM, i.e., the United States, EU4 (Germany, France,… Continue reading SOLIRIS Drug Insight and Market Forecasts, 2019-2032: The First Therapy Approved to Treat Patients with PNH
Category: Newswire
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth – Technavio
NEW YORK, Dec. 7, 2023 /PRNewswire/ — The amyotrophic lateral sclerosis treatment market is expected to grow by USD 663.7 million from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 12.79% during the forecast period, according to Technavio Research. The market is segmented by Type (Intravenous and Oral), Distribution Channel… Continue reading Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth – Technavio
Citizen Watch America Celebrates Opening of Fifth Avenue CITIZEN FLAGSHIP STORE NEW YORK
The premiere retail destination offers an immersive shopping experience with Accutron, Alpina, Bulova, Citizen, and Frederique Constant brands NEW YORK, Dec. 7, 2023 /PRNewswire/ — Citizen Watch America (CWA), a leader in accessible luxury timepieces, marked the official opening of the group’s first-ever U.S.-based multi-brand flagship store yesterday evening. CITIZEN FLAGSHIP STORE NEW YORK, situated within… Continue reading Citizen Watch America Celebrates Opening of Fifth Avenue CITIZEN FLAGSHIP STORE NEW YORK
Fiji Airways partners with JetBlue
National Airline continues to grow its footprint in North America NADI, Fiji, Dec. 7, 2023 /PRNewswire/ — Fiji Airways, Fiji’s National Airline is proud to announce a new interline partnership with JetBlue based out of the United States. The partnership means guests can purchase fares on both airlines on the one ticket, seamlessly connecting customers between… Continue reading Fiji Airways partners with JetBlue
Metrology Services Market to grow by USD 1.20 billion between 2023 – 2028; Growing adherence to global quality standards boosts the market growth – Technavio
NEW YORK, Dec. 7, 2023 /PRNewswire/ — The metrology services market by application (heavy equipment, automotive, aerospace and defense, and others), product (coordinate measuring machines (CMM), optical digitizers, and scanners (ODS)), and geography (Europe, APAC, North America, South America, and Middle East and Africa) – Forecast and Analysis 2024-2028 report has been added to Technavio offering. With ISO 9001:2015… Continue reading Metrology Services Market to grow by USD 1.20 billion between 2023 – 2028; Growing adherence to global quality standards boosts the market growth – Technavio
Power & Utilities Sector Innovation: Tech-Driven Transformation of Power Transmission Lines
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Power Lines in Utilities 2.0 – How Tech is Driving the Sector Innovation” report has been added to ResearchAndMarkets.com’s offering. The power & utilities sector is leveraging technologies such as intelligent monitoring, digital twins, AI, robotics, and IoT to boost the efficiency, safety, and reliability of power transmission lines.… Continue reading Power & Utilities Sector Innovation: Tech-Driven Transformation of Power Transmission Lines
Regor Announces Promising Safety And Single Agent Efficacy Data Evaluating RGT-419B In HR+/HER2- Advanced Breast Cancer Patients Who Have Progressed On CDK4/6 Inhibitors And Endocrine Therapy
RGT-419B, a next generation CDK4 inhibitor, was safe and well tolerated in a First-in-Human Phase 1A single agent dose escalation study. Monotherapy clinical efficacy was observed in HR+/HER2- advanced breast cancer (ABC) patients who have progressed on CDK4/6 inhibitors (CDK4/6is) and endocrine therapy (ET). The current data support the continued development of RGT-419B as a… Continue reading Regor Announces Promising Safety And Single Agent Efficacy Data Evaluating RGT-419B In HR+/HER2- Advanced Breast Cancer Patients Who Have Progressed On CDK4/6 Inhibitors And Endocrine Therapy
Affective Computing Market to grow by USD 236.41 billion from 2023 to 2028; increasing demand for affective computing from the media and entertainment industry to boost market growth- Technavio
NEW YORK, Dec. 7, 2023 /PRNewswire/ — The Affective Computing Market is segmented by component (software and hardware), technology (touch-based and touch-less), and geography (North America, Europe, APAC, South America, and Middle East and Africa) – Forecast and Analysis 2024-2028″ report has been added to Technavio offering. With ISO 9001:2015 certification, Technavio has proudly partnered with more than… Continue reading Affective Computing Market to grow by USD 236.41 billion from 2023 to 2028; increasing demand for affective computing from the media and entertainment industry to boost market growth- Technavio
Cúpula da México 2023: Unindo empresas mexicanas e chinesas para um sucesso compartilhado
CIDADE DO MÉXICO, 7 de dezembro de 2023 /PRNewswire/ — Em 6 de dezembro, a Cúpula da Huawei Cloud México foi realizado com sucesso na Cidade do México, reunindo clientes e parceiros para discutir o desenvolvimento da economia digital do México. Na Cúpula, a Huawei Cloud não apenas compartilhou as mais recentes práticas de inovação… Continue reading Cúpula da México 2023: Unindo empresas mexicanas e chinesas para um sucesso compartilhado
Invossa Emerging Drug Insights and Market Forecasts, 2019-2032: An Allogeneic (donor) Cell and Gene Therapy
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Invossa Emerging Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about invossa for osteoarthritis in the six major markets. A detailed picture of the invossa for osteoarthritis in the 6MM, i.e., the United States, EU4 (Germany, France, Italy,… Continue reading Invossa Emerging Drug Insights and Market Forecasts, 2019-2032: An Allogeneic (donor) Cell and Gene Therapy